# Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

> **NCT07581288** · — · NOT_YET_RECRUITING · sponsor: **University of British Columbia** · enrollment: 50 (estimated)

## Conditions studied

- Uterine Bleeding
- Uterine Cancer
- Uterine Neoplasms
- Endometrial Cancer
- Endometrial Hyperplasia
- Endometrial Intraepithelial Neoplasia
- Menstrual Cycle
- Reproductive Endocrinology

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07581288
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07581288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07581288, "Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT07581288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*